Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
| Status: | Completed |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | October 2006 |
| End Date: | July 2015 |
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
The purpose of this study is to examine the health behaviors of melanoma survivors. We want
to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of
people being diagnosed with melanoma is growing. Many people who are diagnosed with melanoma
are young. Little research has been done to find out how melanoma survivors feel years after
they have been treated.
to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of
people being diagnosed with melanoma is growing. Many people who are diagnosed with melanoma
are young. Little research has been done to find out how melanoma survivors feel years after
they have been treated.
The rapidly rising incidence and mortality rates of melanoma, the most fatal form of skin
cancer, are among the greatest increases of all preventable cancers over the past decade.
However, because of recent advances in early detection, secondary prevention efforts, and
treatment, the number of melanoma survivors is increasing. Little research has been
conducted on melanoma survivors and important opportunities exist for research in this
understudied population. Understanding recurrence and second primary cancer risk, cognitive
characteristics, behaviors, surveillance patterns, economic sequelae, and family issues of
melanoma survivors is imperative from a public health standpoint to promote the health and
well-being of this cohort. The objectives of this study are to: 1) conduct focus groups to
enhance our understanding of the behaviors of melanoma survivors, and 2) conduct a pilot
survey study based on the results of the focus groups to further describe the behavioral and
psychosocial issues in melanoma survivors. This will be among the first studies that
explores behavioral and psychosocial issues in melanoma survivors. The study findings will
inform a large-scale melanoma survivorship grant proposal to the National Cancer Institute
or other federal/private sources of funding.
cancer, are among the greatest increases of all preventable cancers over the past decade.
However, because of recent advances in early detection, secondary prevention efforts, and
treatment, the number of melanoma survivors is increasing. Little research has been
conducted on melanoma survivors and important opportunities exist for research in this
understudied population. Understanding recurrence and second primary cancer risk, cognitive
characteristics, behaviors, surveillance patterns, economic sequelae, and family issues of
melanoma survivors is imperative from a public health standpoint to promote the health and
well-being of this cohort. The objectives of this study are to: 1) conduct focus groups to
enhance our understanding of the behaviors of melanoma survivors, and 2) conduct a pilot
survey study based on the results of the focus groups to further describe the behavioral and
psychosocial issues in melanoma survivors. This will be among the first studies that
explores behavioral and psychosocial issues in melanoma survivors. The study findings will
inform a large-scale melanoma survivorship grant proposal to the National Cancer Institute
or other federal/private sources of funding.
Inclusion Criteria:
For the focus group recruitment (Specific Aim 1) - Patients with melanoma (invasive
primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 1996-2005
For the survey group recruitment (Specific Aim 2):
patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been
treated at MSKCC from 2001-2011• Ability to sign informed consent which indicates the
psychosocial, behavioral, epidemiological nature of this study
• Age ≥ or = to 18 years and fluent in the English language
Exclusion Criteria:
- Patients with intraepithelial (in situ) melanoma
- Patients with stage IV melanoma
- Patients with nodal or visceral melanoma without a documented primary lesion
- Patients with prior malignancies For the focus group recruitment (Specific Aim
1): (patients treated at MSKCC from 1996-2005) who have a diagnosis >10 years
ago from treatment. For the survey group recruitment (Specific Aim 2): patients
treated at MSKCC from 2001-2011)who have a diagnosis >10 years ago from
treatment.
- Patients with a recent diagnosis of melanoma, <12 months
- Patients who are one year or more post diagnosis and are still receiving
treatment for their melanoma
We found this trial at
1
site
Click here to add this to my saved trials
